Lifestyle intervention for gestational diabetes mellitus prevention: A cluster-randomized controlled study  by Wang, Shuang et al.
Available online at www.sciencedirect.comScienceDirect
Chronic Diseases and Translational Medicine 1 (2015) 169e174
www.keaipublishing.com/en/journals/cdtm/Original article
Lifestyle intervention for gestational diabetes mellitus prevention:
A cluster-randomized controlled study
Shuang Wang, Jing-Mei Ma, Hui-Xia Yang*
Department of Obstetrics and Gynaecology, Peking University First Hospital, Beijing 100034, China
Received 23 August 2015
Available online 22 October 2015
www.cdatm.orgAbstractObjective: The study was to examine whether gestational diabetes mellitus (GDM) can be prevented by early trimester lifestyle
counseling in a high-risk population.
Methods: From September 2012 to January 2013, 1664 pregnancies in the Department of Obstetrics and Gynecology of First
Hospital of Peking University were enrolled in the study during their first prenatal care visit before the 8 gestational weeks visit and
asked to fill out a questionnaire on GDM risk evaluation. According to the questionnaire and medical records, those with at least one
risk factor of GDM were included in the intervention study and randomly allocated to two groups, intervention group and control
group. Routine prenatal care was offered, while standardized two-step lifestyle intervention was provided to the intervention group
during 6e8 gestational weeks, and at 12e13 gestational weeks, enforcement intervention based on maternal anthropometrics were
offered. Both groups were followed until 75 g oral glucose tolerance test (OGTT) testing at 24e28 gestational weeks. The weight
gain after intervention and the prevalence of GDM were used to evaluate the effect.
Results: (1) According to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria, the positive
rate of GDM for the intervention group was 17.16% (23/134), lower than the control group which was 23.91% (33/138), P¼ 0.168.
(2) Theweight gain during the first and second trimester for the intervention group was (1.38 ± 2.34) kg and (5.51± 2.18) kg, lower
than in the control group which was (1.41 ± 2.58) kg and (5.66 ± 2.25) kg, (P ¼ 0.905, P ¼ 0.567). (3) Positive rate of GDM for
those fasting plasma glucose (FPG) 5.1 mmol/L during early pregnancy was 11/36 (30.55%) for the intervention group that was
lower than 17/37 (45.95%) for the control group, but the statistical difference was not significant (P ¼ 0.076).
Conclusion: The positive rate of GDM could be reduced by a certain amount lifestyle intervention from the beginning of preg-
nancy. More validated effective intervention should be explored in the high-risk pregnant women.
© 2015 Chinese Medical Association. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Accumulated evidence has shown that gestational
diabetes mellitus (GDM) is associated with a range of
negative short or long-term health outcomes, both to
pregnant women and their offsprings. Meanwhile,
these adverse effects can produce vicious cycles
across generations.1 Although high-risk factors have
been assessed by several studies, such as advanced
maternal age, obesity, family history of diabetes
mellitus (DM), history of polycystic ovary syndrome
(PCOS), pregnancy history of GDM or macrosomia
from previous pregnancies, limited clinical strategies
for the prevention of GDM have been confirmed.
Specific dietary counseling could be effective for
control of gestational weight gain that might indi-
rectly prevent GDM.2,3 Physical activity-based inter-
vention could also have potential similar effects. In
general, any intervention strategies in need of vali-
dation in the clinic.4,5
Some of the current results of intervention studies
are contradictory. Possible explanations could be the
various intensity and duration of interventions. In
terms of GDM prevention, previous studies were star-
ted at various times, from pre-pregnancy to second
trimester. Considering the gradual aggravation of in-
sulin resistance, intervention after the first trimester
could be too late or of too short duration for
prevention.
In this pilot study, a cluster-randomized trial was
conducted in the Department of Obstetrics and Gyne-
cology, Peking University First Hospital, pregnancies
with more than one risk factor of GDM were enrolled
and randomized to lifestyle intervention or a control
group. For intervention group, standardized two-step
intervention with individual education on “appro-
priate dietary, physical activity, and weight gain during
pregnancy” was initiated from early in the first
trimester with subsequent enforcement of education
based on anthropometrics at 12e13 gestational weeks.
Follow-up was until 24e28 gestational weeks, and the
incidence of GDM was used to evaluate the effect of
intervention.
Methods
Cases recruitment and workflow
Ethical approvals were obtained from the institu-
tional review board of Peking University First Hospi-
tal. Written informed consent was obtained from each
patient.From September 2012 to January 2013, 1,664
singleton pregnancies were enrolled in the study
during their first prenatal care visit before the 8
gestational week visit and asked to fill in a ques-
tionnaire on GDM risk evaluation (age, history of
PCOS, family history of diabetes mellitus, and preg-
nancy history of GDM or macrosomia). Weight and
height were recorded by a nurse. The definition of risk
factors for GDM in the study was as follows: Age
35 years, pre-pregnancy body mass index (BMI)
25 kg/m2, family history of DM, history of PCOS,
history of GDM or macrosomia from a previous
pregnancy. According to questionnaire and medical
records, those with at least one risk factor of GDM
were included in the intervention study and randomly
allocated to one of two groups. The exclusion criteria
were pre-existing diabetes or multiple pregnancy. The
randomization method using exponential random
numbers produced the intervention group and the
control group.
The study design is shown in Fig. 1. In brief, routine
prenatal care was offered, while a standardized two-
step lifestyle intervention was provided to the inter-
vention group during 6e8 gestational weeks, and at
12e13 gestational weeks, enforcement interventions
based on maternal anthropometrics were offered. Both
groups were followed until a 75 g oral glucose toler-
ance test (OGTT) was administered at 24e28 gesta-
tional weeks. The International Association of
Diabetes and Pregnancy Study Groups (IADPSG) cri-
terion was used for GDM diagnosis in the study.
Intervention
The intervention using standardized courses were
given by one physician, and including three courses:
“What is a balanced diet”, “Proper physical activity is
beneficial during pregnancy”, and “Standardweight-gain
during pregnancy”. Key points/take-home messages of
the courses were listed in the Table 1. Each course lasted
for 40e60 minutes and was presented to patients in
groups (fewer than six pregnant participants per group).
The assessment of nutritional status was offered by pro-
fessional nutritional counselors based on the weight gain
and body fat evaluation at 12e13weeks and enforcement
of lifestyle education was offered accordingly.
Outcome assessment
The baseline demographic characteristics were
compared between the two groups, including body fat
composition, and biochemistry indicators of glucose
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Fig. 1. Study design of intervention and assessment. GDM: Gestational diabetes mellitus; OGTT: oral glucose tolerance test; gws: gestational
weeks.
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thropometrics and biochemistry testing were compared.
The primary outcome of the study was the incidence
of GDM to estimate the effect of intervention. The
number of abortions or fetal loss during pregnancy was
recorded.
Statistics
All results are presented as (mean ± SD) unless
otherwise indicated. SPSS 15.0 statistical software
(SPSS Inc. Chicago, IL, USA) was used for data
analysis. Statistical significance was accepted as P
value of <0.05.
Results
According to our study, 17.97% (299/1664) of
pregnancies were found to have high-risk factors ofTable 1
Key points/take-home messages of the course.
1. The definition of a balanced diet during early and mid-late
pregnancy according to the dietary pagoda of pregnant women in
China.
2. Encouragement of appropriate practice if permittedd walking 30
minutes after meal at least once a day.
3. Goal of body weight gain during early and mid-late pregnancy
according to Institute of Medicine of the National Academics, May
2009.GDM. The workflow of recruiting was shown in Fig. 2.
According to fasting glucose testing, patients with
preexisting diabetes were excluded from the study, and
those with incomplete clinical information or who
refused to continue were also excluded. There were
134 women in the intervention group given not only
routine prenatal care but also lifestyle counseling, and
138 women in the control group given nothing but
routine prenatal care.
When we compared the two groups, there was no
significant difference in the basic parameters, including
age, family history of DM, body weight before preg-
nancy, BMI before pregnancy, fasting plasma glucose
(FPG) during early pregnancy, and blood lipid markers
during early pregnancy (cholesterol, high-density li-
poprotein cholesterol (HDL-C), low-density lipopro-
tein cholesterol (LDL-C), fasting plasma insulin level
(FINS) during early pregnancy, and homeostatic Model
Assessment of Insulin Resistance (HOMA-IR)) (Table
2). Therefore, the two groups were comparable.
To evaluate the outcome of intervention, the inci-
dence of GDM was compared as a primary outcome.
According to the IADPSG criteria, the positive rate of
GDM for the intervention group was 17.16%, (23/134)
lower than control group which was 23.91%, (33/138)
but there was no significant difference (P ¼ 0.168).
The secondary outcome was the weight gain during
pregnancy. The weight gain during the first and second
Fig. 2. The workflow of the recruitment. GDM: Gestational diabetes mellitus; OGTT: oral glucose tolerance test.
Table 2




group (n ¼ 134)
P
Age (years) 30.27 ± 3.64 31.01 ± 3.8 0.087
Family history
of DM
51 (36.96) 49 (36.30) 0.947
Pre-pregnancy
BW (kg)
61.36 ± 10.40 60.26 ± 9.73 0.371
Pre-pregnancy
BMI (kg/m2)
23.06 ± 3.63 22.95 ± 3.65 0.798
FPG (mmol/L) 4.93 ± 0.39 4.95 ± 0.40 0.683
TG (mmol/L) 0.95 ± 0.44 1.03 ± 0.55 0.163
TCHO (mmol/L) 4.16 ± 0.83 4.21 ± 0.79 0.621
HDL-C (mmol/L) 1.38 ± 0.34 1.36 ± 0.31 0.667
LDL-C (mmol/L) 2.29 ± 0.77 2.31 ± 0.67 0.779
FINS (ng/ml) 7.25 ± 4.45 7.74 ± 4.75 0.384
HOMA-IR 1.63 ± 1.15 1.74 ± 1.19 0.451
DM: Diabetes mellitus; BW: Body weight; BMI: Body mass index;
FPG: Fasting plasma glucose. TG: Triglyceride; TCHO: Total
cholesterol; HDL: High-density lipoprotein cholesterol; LDL-C:
Low-density lipoprotein cholesterol; FINS: Fasting plasma insulin
level; HOMA-IR: Homeostatic Model Assessment of Insulin Resis-
tance; values are expressed as mean ± SD or n (%).
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(1.38 ± 2.34) kg and (5.51 ± 2.18) kg, lower than for
the control group which was (1.41 ± 2.58) kg and
(5.66 ± 2.25) kg, but there was no significant differ-
ence between the two groups (P ¼ 0.905, P ¼ 0.567)
(Table 3).
Other than the risk factors involved in the study,
another factor, a certain level of FPG in the first
trimester could be one of the important high-risk fac-
tors of GDM. However, this had not been done at the
very beginning of our study. We then further analyzed
outcomes according to FPG (Table 4). It showed that
women with FPG 5.1 mmol/L had significantly
higher BMI, FINS and HOMA-IR than women with
FPG <5.1 mmol/L. When using FPG 5.1 mmol/L at
the first trimester as another risk factor, we found that
the incidence of GDM for those with an FPG
5.1 mmol/L during early pregnancy in the interven-
tion group was 27.78% (10/36). This was lower than in
the control group, which was 45.95% (17/37), but
there was no significant difference (P ¼ 0.076).
Discussion
According to our study, it is not hard to find that
there are many pregnant women with high-risk factorsof GDM among the population, about 17.97% (299/
1664) among our patients. And almost all the relevant
research suggests beginning intervention during the
second trimester (from 12 weeks to 20 weeks),
Table 3
Comparison of weight gain between the HR-0 and HR-1 groups (kg,
mean ± SD).
Items Early-pregnancy Mid-pregnancy
Control group 1.41 ± 2.58 5.66 ± 2.25
Intervention group 1.38 ± 2.34 5.51 ± 2.18
P 0.905 0.567
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In this study we started intervention for the high-risk
population earlier, during the first trimester (from 5
weeks to 12 weeks). We hypothesized that this may
reduce the positive rate of GDM.
From our research, lifestyle intervention given at
the first trimester had a trend of decreasing the positive
rate of GDM, although there was no statistically sig-
nificant difference. We suspect that lack of significance
was related to the size of the sample, which was not big
enough. We hypothesize that if we enlarge the sample
early intervention will appear more effective.
As for another risk factor of GDM, FPG
5.1 mmol/L in the first trimester, we did not put it
into our questionnaire at the beginning of our study
because that evaluation was not being done at that
time. However, from the results of Zhu Weiwei,6 and
the limited data from our study, it did play an important
role in increasing the risk of GDM. Therefore we
should pay more attention to these patients.
A review5 provided a comprehensive overview of
the effect of prenatal physical activity-based inter-
vention on glucose tolerance, insulin sensitivity, and
GDM prevention. Of the eight articles reviewed, only
three of them showed that it may help to achieve good
glycemic control and limit insulin use in GDM
women. Only 16%e55% compliance appears to be aTable 4
Baseline comparison of women with FPG 5.1 mmol/L and FPG
<5.1 mmol/L (mean ± SD).
Items 5.1 mmol/L <5.1 mmol/L P
(n ¼ 114) (n ¼ 313)
BMI (kg/m2) 23.09 ± 3.62 21.99 ± 2.95 0.001a
FINS (ng/ml) 9.30 ± 5.80 6.13 ± 2.89 <0.001a
HOMA-IR 2.25 ± 1.48 1.30 ± 0.64 <0.001a
TG (mmol/L) 0.98 ± 0.56 0.92 ± 0.45 0.267
TCHO (mmol/L) 4.23 ± 0.77 4.09 ± 0.79 0.094
HDL-C (mmol/L) 1.31 ± 0.27 1.40 ± 0.33 0.008a
LDL-C (mmol/L) 2.33 ± 0.66 2.21 ± 0.69 0.094
a P < 0.05. BMI: Body mass index; FINS: Fasting plasma insulin
level; HOMA-IR: Homeostatic Model Assessment of Insulin Resis-
tance. TG: Triglyceride; TCHO: Total cholesterol; HDL: High-
density lipoprotein cholesterol; LDL-C: Low-density lipoprotein
cholesterol.main problem in physical activity-based intervention
studies to prevent GDM. However, another article7
about practice intervention had pointed out that
physical activity during early pregnancy could help
reduce the positive rate of GDM around 24% (odd
ratio, OR: 0.76; 95% CI: 0.70e0.83). Besides, a meta-
analysis8 of dietary-based intervention and GDM
prevention had reported that with good compliance,
dietary intervention started during early pregnancy
could significantly reduce the positive rate of GDM.
Generally speaking, the moderate way of exercise and
starting time of lifestyle intervention and the compli-
ance of pregnant women all play an important role in
GDM prevention.
There were several factors that could explain the
results of our study. First, the goal of controlling
weight gain was not thoroughly achieved, which was
also mentioned by a review article.5 Secondly, the size
of sample was not big enough to determine signifi-
cance between the two groups, which was increasing as
the study went on. Thirdly, there was unknown
compliance, the same problem as other studies had
pointed out. We have not yet found a good way to
evaluate the compliance of the pregnant women with
intervention, which we need to increase our efforts.
And last, due to the profound cognition of and atten-
tion to GDM in our hospital, the control group might
also have received some guidance from their doctors,
including eating a healthy diet and moderate exercise,
which may affect the result of our study.
In conclusion, the positive rate of GDM could be
reduced by certain lifestyle interventions from the
beginning of pregnancy. More validated effective
intervention should be explored for the high-risk
pregnant women.
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